BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25183659)

  • 1. X-linked Alport syndrome caused by splicing mutations in COL4A5.
    Nozu K; Vorechovsky I; Kaito H; Fu XJ; Nakanishi K; Hashimura Y; Hashimoto F; Kamei K; Ito S; Kaku Y; Imasawa T; Ushijima K; Shimizu J; Makita Y; Konomoto T; Yoshikawa N; Iijima K
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1958-64. PubMed ID: 25183659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
    Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
    Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
    Malone AF; Funk SD; Alhamad T; Miner JH
    Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome.
    Horinouchi T; Nozu K; Yamamura T; Minamikawa S; Omori T; Nakanishi K; Fujimura J; Ashida A; Kitamura M; Kawano M; Shimabukuro W; Kitabayashi C; Imafuku A; Tamagaki K; Kamei K; Okamoto K; Fujinaga S; Oka M; Igarashi T; Miyazono A; Sawanobori E; Fujimaru R; Nakanishi K; Shima Y; Matsuo M; Ye MJ; Nozu Y; Morisada N; Kaito H; Iijima K
    J Am Soc Nephrol; 2018 Aug; 29(8):2244-2254. PubMed ID: 29959198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Functional Analysis in vitro of 2 COL4A5 Splicing Mutations at the Same Site in 2 Unrelated Alport Syndrome Chinese Families.
    Lv X; Wu WQ; Zhang JX; Miao LF; Yu BZ; Chen FF; Cui YX; Xia ZK; Liu ZH; Li XJ
    Cytogenet Genome Res; 2020; 160(5):238-244. PubMed ID: 32659759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
    Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
    Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts.
    Wang F; Wang Y; Ding J; Yang J
    Kidney Int; 2005 Apr; 67(4):1268-74. PubMed ID: 15780079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome.
    Hertz JM; Juncker I; Persson U; Matthijs G; Schmidtke J; Petersen MB; Kjeldsen M; Gregersen N
    Hum Mutat; 2001 Aug; 18(2):141-8. PubMed ID: 11462238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain.
    Hashimura Y; Nozu K; Kaito H; Nakanishi K; Fu XJ; Ohtsubo H; Hashimoto F; Oka M; Ninchoji T; Ishimori S; Morisada N; Matsunoshita N; Kamiyoshi N; Yoshikawa N; Iijima K
    Kidney Int; 2014 May; 85(5):1208-13. PubMed ID: 24304881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
    Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome.
    King K; Flinter FA; Nihalani V; Green PM
    Hum Genet; 2002 Dec; 111(6):548-54. PubMed ID: 12436246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant splicing of the COL4A5 gene in patients with Alport syndrome.
    Lemmink HH; Kluijtmans LA; Brunner HG; Schröder CH; Knebelmann B; Jelínková E; van Oost BA; Monnens LA; Smeets HJ
    Hum Mol Genet; 1994 Feb; 3(2):317-22. PubMed ID: 8004101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COL4A5 splice site mutation and alpha 5(IV) collagen mRNA in Alport syndrome.
    Netzer KO; Pullig O; Frei U; Zhou J; Tryggvason K; Weber M
    Kidney Int; 1993 Feb; 43(2):486-92. PubMed ID: 8441246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic evaluation of synonymous COL4A5 variants in X-linked Alport syndrome using a minigene assay.
    Horinouchi T; Yamamura T; Minamikawa S; Nagano C; Sakakibara N; Nakanishi K; Shima Y; Morisada N; Ishiko S; Aoto Y; Nagase H; Takeda H; Rossanti R; Ishimori S; Kaito H; Matsuo M; Iijima K; Nozu K
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1342. PubMed ID: 32543079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three exonic variants in the COL4A5 gene alter RNA splicing in a minigene assay.
    Zhang R; Lang Y; Shi X; Zhang Y; Liu X; Pan F; Qiao D; Teng X; Shao L
    Mol Genet Genomic Med; 2024 Feb; 12(2):e2395. PubMed ID: 38400605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A wave of deep intronic mutations in X-linked Alport syndrome.
    Boisson M; Arrondel C; Cagnard N; Morinière V; Arkoub ZA; Saei H; Heidet L; Kachmar J; Hummel A; Knebelmann B; Bonnet-Dupeyron MN; Isidor B; Izzedine H; Legrand E; Couarch P; Gribouval O; Bole-Feysot C; Parisot M; Nitschké P; Antignac C; Dorval G
    Kidney Int; 2023 Aug; 104(2):367-377. PubMed ID: 37230224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Splicing Mutation Identified in a Chinese Family with X-linked Alport Syndrome Using Targeted Next-Generation Sequencing.
    Chen C; Lu CX; Wang Q; Cao LH; Luo Y; Zhang X
    Genet Test Mol Biomarkers; 2016 Apr; 20(4):203-7. PubMed ID: 26866448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the pathogenicity of known COL4A5 intronic variants by in vitro splicing assay.
    Horinouchi T; Nozu K; Yamamura T; Minamikawa S; Nagano C; Sakakibara N; Nakanishi K; Shima Y; Morisada N; Ishiko S; Aoto Y; Nagase H; Takeda H; Rossanti R; Kaito H; Matsuo M; Iijima K
    Sci Rep; 2019 Sep; 9(1):12696. PubMed ID: 31481700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-tier approach to mutation detection in the COL4A5 gene for Alport syndrome.
    King K; Flinter FA; Green PM
    Hum Mutat; 2006 Oct; 27(10):1061. PubMed ID: 16941480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.